SCHEMBL6409864

SCHEMBL6409864

O=C(NCc1ccccc1)OC1=NOC2(CCN(C(=O)c3ccc(Br)cc3)CC2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPK8 P45983 2/20 0.43
MAPK10 P53779 2/20 0.43
LMNA P02545 1/20 0.42
HTR1A P08908 1/20 0.40
HTR1B P28222 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
MME P08473 1/20 0.40
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409843 0.91 CYP3A4 (0.47) KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL6410565 0.89 CYP2D6 (0.51) KMT2ASMN1; SMN2MAPK8MAPK10MAPT
SCHEMBL6415977 0.86 ABL1 (0.41) KMT2ASMN1; SMN2LMNAHPGDALDH1A1
SCHEMBL6410146 0.86 TSHR (0.43) LMNAMMEHPGDALDH1A1HTT
SCHEMBL6410103 0.84 CYP2D6 (0.42) KMT2AMAPTHPGDGAAALDH1A1
SCHEMBL6409695 0.84 HTR1A (0.49) HTR1A
SCHEMBL6409750 0.84 HPGD (0.47) KMT2ASMN1; SMN2LMNAMMEHPGD
SCHEMBL6415660 0.84 SMN1; SMN2 (0.36) KMT2ASMN1; SMN2LMNAMAPTHPGD
SCHEMBL2404875 0.84 SMN1; SMN2 (0.49) KMT2ASMN1; SMN2MAPK8MAPK10LMNA
SCHEMBL6413167 0.82 FPR3 (0.37) KMT2ASMN1; SMN2LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed